Viesosios istaigos Vilniaus universiteto ligonines Santaros kliniku filialas Nacionalinis vezio centras

The medical center is at the forefront of oncology research, focusing on innovative treatments for advanced/metastatic non-small cell lung cancer (NSCLC). By integrating cutting-edge therapies with standard care, the center aims to enhance patient outcomes and quality of life.

• Advanced Lung Cancer Therapies
• Combination Treatment Strategies
• Immunotherapy Advancements

Through its pioneering research, the center contributes significantly to the development of new therapeutic approaches, offering hope to patients with challenging cancer diagnoses.

Specializing in immunotherapy, the center explores the potential of immune system modulation to combat cancer. By combining novel agents with established treatments, researchers aim to unlock new pathways for cancer management.

• Immune Checkpoint Inhibitors
• Combination Immunotherapy
• PD-L1 Unselected Population Studies

The center's work in this field is instrumental in advancing our understanding of how the immune system can be harnessed to fight cancer, paving the way for more personalized and effective treatment options.

In the realm of pharmacology, the center is dedicated to the study of drug interactions and efficacy in cancer treatment. By evaluating the synergistic effects of combining new drugs with existing therapies, the center seeks to optimize treatment protocols.

• Drug Efficacy Studies
• Combination Chemotherapy
• Pharmacokinetic Research

Through rigorous research and clinical trials, the center plays a crucial role in refining cancer treatment regimens, ultimately aiming to improve patient survival rates and quality of life.